![]()
|
|
||||||||
(Received for publication, August 15, 1996, and in revised form, October 30, 1996)
From the Institute of Pharmacology and Toxicology, University of
Lausanne, 27 Rue du Bugnon, 1005 Lausanne, Switzerland
GLUT2 expression is strongly decreased in
glucose-unresponsive pancreatic
Volume 272, Number 6,
Issue of February 7, 1997
pp. 3216-3222
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Cells
COMPARISON WITH THE EFFECTS OF FATTY ACIDS
cells of diabetic rodents. This
decreased expression is due to circulating factors distinct from
insulin or glucose. Here we evaluated the effect of palmitic acid and
the synthetic glucocorticoid dexamethasone on GLUT2 expression by
in vitro cultured rat pancreatic islets. Palmitic acid
induced a 40% decrease in GLUT2 mRNA levels with, however, no
consistent effect on protein expression. Dexamethasone, in contrast,
had no effect on GLUT2 mRNA, but decreased GLUT2 protein by about
65%. The effect of dexamethasone was more pronounced at high glucose
concentrations and was inhibited by the glucocorticoid antagonist
RU-486. Biosynthetic labeling experiments revealed that GLUT2
translation rate was only minimally affected by dexamethasone, but that
its half-life was decreased by 50%, indicating that glucocorticoids
activated a posttranslational degradation mechanism. This degradation
mechanism was not affecting all membrane proteins, since the
subunit of the Na+/K+-ATPase was unaffected.
Glucose-induced insulin secretion was strongly decreased by treatment
with palmitic acid and/or dexamethasone. The insulin content was
decreased (~55 percent) in the presence of palmitic acid, but
increased (~180%) in the presence of dexamethasone. We conclude that
a combination of elevated fatty acids and glucocorticoids can induce
two common features observed in diabetic
cells, decreased GLUT2
expression, and loss of glucose-induced insulin secretion.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Koizumi and T. Yada Sub-chronic stimulation of glucocorticoid receptor impairs and mineralocorticoid receptor protects cytosolic Ca2+ responses to glucose in pancreatic {beta}-cells J. Endocrinol., May 1, 2008; 197(2): 221 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Gartner, G. Vila, T. Daneva, A. Nabokikh, F. Koc-Saral, A. Ilhan, O. Majdic, A. Luger, and L. Wagner New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E347 - E354. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ranta, D. Avram, S. Berchtold, M. Dufer, G. Drews, F. Lang, and S. Ullrich Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes, May 1, 2006; 55(5): 1380 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Oberkofler, K. Klein, T. K. Felder, F. Krempler, and W. Patsch Role of Peroxisome Proliferator-Activated Receptor-{gamma} Coactivator-1{alpha} in the Transcriptional Regulation of the Human Uncoupling Protein 2 Gene in INS-1E Cells Endocrinology, February 1, 2006; 147(2): 966 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Jacobson, T. W. von Geldern, L. Ohman, M. Osterland, J. Wang, B. Zinker, D. Wilcox, P. T. Nguyen, A. Mika, S. Fung, et al. Hepatic Glucocorticoid Receptor Antagonism Is Sufficient to Reduce Elevated Hepatic Glucose Output and Improve Glucose Control in Animal Models of Type 2 Diabetes J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ullrich, S. Berchtold, F. Ranta, G. Seebohm, G. Henke, A. Lupescu, A. F. Mack, C.-M. Chao, J. Su, R. Nitschke, et al. Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Mediates Glucocorticoid-Induced Inhibition of Insulin Secretion Diabetes, April 1, 2005; 54(4): 1090 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stellato Post-transcriptional and Nongenomic Effects of Glucocorticoids Proceedings of the ATS, November 1, 2004; 1(3): 255 - 263. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gesina, F. Tronche, P. Herrera, B. Duchene, W. Tales, P. Czernichow, and B. Breant Dissecting the Role of Glucocorticoids on Pancreas Development Diabetes, September 1, 2004; 53(9): 2322 - 2329. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens cFLIP Protein Prevents Tumor Necrosis Factor-{alpha}-Mediated Induction of Caspase-8-Dependent Apoptosis in Insulin-Secreting {beta}Tc-Tet Cells Diabetes, June 1, 2002; 51(6): 1805 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Blondeau, J. Lesage, P. Czernichow, J. P. Dupouy, and B. Breant Glucocorticoids impair fetal {beta}-cell development in rats Am J Physiol Endocrinol Metab, September 1, 2001; 281(3): E592 - E599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Weinhaus, N. V. Bhagroo, T. C. Brelje, and R. L. Sorenson Dexamethasone Counteracts the Effect of Prolactin on Islet Function: Implications for Islet Regulation in Late Pregnancy Endocrinology, April 1, 2000; 141(4): 1384 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Guner, P. R. Kiela, H. Xu, J. F. Collins, and F. K. Ghishan Differential regulation of renal sodium-phosphate transporter by glucocorticoids during rat ontogeny Am J Physiol Cell Physiol, November 1, 1999; 277(5): C884 - C890. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.E. Adams, H. Sakurai, and B.M. Adams Effect of Stress-Like Concentrations of Cortisol on Estradiol-Dependent Expression of Gonadotropin-Releasing Hormone Receptor in Orchidectomized Sheep Biol Reprod, January 1, 1999; 60(1): 164 - 168. [Abstract] [Full Text] |
||||
![]() |
S. Gremlich, C. Bonny, G. Waeber, and B. Thorens Fatty Acids Decrease IDX-1 Expression in Rat Pancreatic Islets and Reduce GLUT2, Glucokinase, Insulin, and Somatostatin Levels J. Biol. Chem., November 28, 1997; 272(48): 30261 - 30269. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Davani, A. Khan, M. Hult, E. Martensson, S. Okret, S. Efendic, H. Jornvall, and U. C. T. Oppermann Type 1 11beta -Hydroxysteroid Dehydrogenase Mediates Glucocorticoid Activation and Insulin Release in Pancreatic Islets J. Biol. Chem., November 3, 2000; 275(45): 34841 - 34844. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Thorens, M.-T. Guillam, F. Beermann, R. Burcelin, and M. Jaquet Transgenic Reexpression of GLUT1 or GLUT2 in Pancreatic beta Cells Rescues GLUT2-null Mice from Early Death and Restores Normal Glucose-stimulated Insulin Secretion J. Biol. Chem., July 28, 2000; 275(31): 23751 - 23758. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dupraz, S. Cottet, F. Hamburger, W. Dolci, E. Felley-Bosco, and B. Thorens Dominant Negative MyD88 Proteins Inhibit Interleukin-1beta /Interferon-gamma -mediated Induction of Nuclear Factor kappa B-dependent Nitrite Production and Apoptosis in beta Cells J. Biol. Chem., November 22, 2000; 275(48): 37672 - 37678. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cottet, P. Dupraz, F. Hamburger, W. Dolci, M. Jaquet, and B. Thorens SOCS-1 Protein Prevents Janus Kinase/STAT-dependent Inhibition of beta Cell Insulin Gene Transcription and Secretion in Response to Interferon-gamma J. Biol. Chem., July 6, 2001; 276(28): 25862 - 25870. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |